Skip to search formSkip to main contentSkip to account menu

LCB 2853

Known as: LCB-2853 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PhenylacetatesSulfonamides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
Pharmacodynamics and antithrombotic effects after intravenous administration of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl…
The antiplatelet and antithrombotic activities of LCB 2853 (sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)